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Because Japanese patients with complementation 
group A xeroderma pigmentosum (XP-A) show early 
skin cancer and severe neurologic dysfunction, their 
family members are greatly concerned about the risk 
of inherited disease. In contrast to western XP-A 
patients, almost all Japanese XP-A patients have two 
of the three mutations (nonsense mutation in exon 3, 
splicing mutation in intron 3, and non-sense muta-
tion in exon 6), which are easily detected by polymer-
ase chain reaction-restriction fragment length poly-
morphism (PCR-RFLP) analysis. This work was 
aimed to see whether PCR-RFLP analysis is useful for 
genetic counseling of XP patients' siblings who are 
potential carriers of an XP-A gene tnutation. In two 
of the three case studies presented, the probands 
were homozygous for the splicing mutation in intron 
3 of the gene. In their siblings receiving genetic 
T here are seven genetic complem entation groups (A through G) of xeroderma pigmentosum (XP), ill-eluding six excision repair-deficient types and one variant type (Cleaver and Bootsma, 1975; Kraemer and Slor, 1985; Kraemer et a/, 1987). Group A XP 
(XP-A) patients are th e most prevalent type i11 Japan (Takebe eta/, 
1977, 1987), accounting for about 40'X, of Japan ese XP patients 
(Nishigori, 1993). In addition to sun sensitivity, these patients show 
progressive neumlogic abnormaJjties. M ental retardation, walking 
impairment, speaking difficulty, and hearing loss are apparent in 
early childhood (Robbins et a/, 1983; Mimak:i et a/, 1986; Robbins , 
1988), and constipation, hypothermia, dysuria , dysphagia, and a 
completely bedridden condition occur in adulthood (Sato, 1993). 
T he pl.ight ofXP-A patients strongly motivates their siblings to seek 
genetic counseln1g. 
Three major mutation sites of the XP-A gene have been detected 
in Japanese patients (Fig 1). The most preva lent one is at the 
acceptor site (AG to AC) of intron 3 of the gene (13 mutation); the 
other Jess preva lent ones are at codon 116 (TAT to T AA) in exon 
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counseling, no mutation was found in the mutation 
site in one case, and one splicing mutation was found 
in the second case. In the third case, the proband was 
a compound heterozygote for the splicing mutation 
and for an unidentified mutation; in her sibling, no 
mutation was found in either of these mutation sites. 
No mutation was found in the siblings' spouses. On 
the basis of these findings, we reassured the prospec-
tive parents that there was little probability ofhaving 
XP children, but in the second and third cases, we 
told them that their apparently unaffected children 
might be carriers. Each couple subsequently had one 
unaffected child. Thus, PCR-RFLP analysis is useful 
for genetic counseling of family members of XP-A 
patients. Key words: XP-A geuelgene fi'equency. J Invest 
Dermatol 108:306-309, 1997 
3 and codon 228 (CGA to TGA) in exon 6 (Tanaka el a/, 1990; 
Satokata el a/, 1992). The three mutations are base substitutions, 
and they are easily detected by polymerase chain reaction- restric-
tion fragment length polymorphism (PCR-RFLP). Because XP-A 
is due to mutations in each allele of a gene and the great majority 
of these mutations arc at one of three known sites, this disorder is 
an ideal ca ndidate for molecular diagnosis of patients and carriers. 
Therefore, we used PCR-RFLP analysis as an aid in genetic 
co unseling of prospective parents who are phenotypica lly normal 
siblings of XP-A pati ents . A priori, half of the offspring of two 
parents who are carriers for XP-A wil l themselves be expected to 
be carriers. Given that a sibling of an XP- A patient is phenotypically 
normal, however, his or her conditional probability of being a gene 
carrier is 2/3. 
MATER.IALS AND METHODS 
Case Reports XPll OS (Take be e/ a/, 1977), born in 1974, is homozy-
gous for the 13 mutation. In 1993, when she was 19 y old, her first e lder 
brother came to us for genetic counseling becanse his wife had become 
pregnant. XP220S (Horiko eta/, 1983), born in 1.969, was homozygous for 
the l3 mutation . When he died in 1990 at age 21, his elder sister and her 
husband, who had a hea lthy inf.1n t son, came to us for genetic counseling. 
XPBOS (Takebe et a/, 1977), born in 1972, was he terozygous for the 13 
mutation and had neither of the other two mutations. She was thus 
considered to have an unidentifi ed mutation of the Xl'-A gene on the other 
allele. Her elder brother and his fiancee came to us for genetic counscl.ing 
in 1993, 2 y before her death at age 22. 
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Figure 1. Th.ree major mutations in Japanese XP-A patients. T he 
three major mutations of the XP-A gene in Japanese XP-A patients arc 
non-sense 111utation in cxon 3, splicing n1utntion in intron 3 (13), which 
leads to a non-sense codon by frame shift, and non-sense mutation in cxon 
6, which can be detected by restriction enzymes J\1/sel. Alu•Nl, and 1-lphl, 
respectively. T he prevalence of the mutation s in the Japanese population is 
in the order 13 , exon 6, and exon 3. 
Cells and Culture Conditions Fibroblasts of each XP-A patient and of 
his or her siblings and spouses were cul tured from a skin biopsy in 
Dulbecco 's modified Eagle 's min.imum essential medium containing 10-
12% fetal bovine serum (Sato et nl, 1988; Sato and Yoshikawa, 1.992). 
Cultures were main ta ined at 3 7°C in a humidified 10% C02 atmosphere. 
DNA Extraction Tota l genomic DNA was extracted from the cu.l tured 
fibrob lasts as described previously (Sambrook e/ n/, 1989). Briefly, the cells 
were rinsed with phosphate-buffered saLine and lysed in STE (STE: 100 mM 
NaCl, 20 mM Tris-Cl pH 8.0, 60 mM ethylenediamine tetraacetic acid) 
with l~ase and proteinase Kat 37°C overnight. DNA was extracted with 
phenol-chloroform-isoamylalcohol (25:24:1) and precipitated with ethano l. 
Amplification of DNA Fragments of the XP-A Gene Three 
genomic DNA fragm ents of the XP-A gene were amplified from the 
extracted DNA by PCR. Amplification of the f.i·agmcnts with Tnq DNA 
polymerase (Perkin-Elmer Cetus, Norwalk, CT) was carried out with an 
automatic thennocyclcr (PC-700; ASTEC, Fukuoka, Japan), as described 
(Saiki e/ nl, 1988). Primers 31 and 32, 41 and 42, and 61 and 62 were used 
to amplify the three DNA fi·agments (Satokata r1 nl , 1992). To determine 
vvhcther there were an y 1nutatio ns i_n the three n1utation sites. \..Ve treated the 
PCR products with ~cstriction endonuclcascs Msel. Alu•Nl. and Hph l , 
respectively. 
RESULTS 
The probability that a patient's sibling wou ld have an afFected child 
was calculated fi·om the risk (zero or 1/2, with the exception noted 
below, as determined b y PCR-R..FLP) of his or h er transmitting a 
mutated XP-A gen e multiplied by the ri sk of the spouse's trans-
mitting a mutated XP-A gene, calculated as follows: 1./2 if PCR-
R.FLP revea led o ne of the common muta tions and zero or 1/2 X 
1/ 376 X 6/178 if PCR..-RFLP revealed no mutations in the three 
common mutation sites, where 1/376 was derived from the rate of 
XP-A carrie rs and 6/ 178 was the rate ofXP-A carrie rs who have an 
XP- A mutation unidentified by PCR-RFLP. 
Case 1 The brother of XP110S was heterozygous for the !3 
mutation . In his wife, no mutation was found in the three common 
mutation sites. PCR-RFLP analysis of the 13 mutation is shown in 
Fig 2. From the result (genotype combination 3 in Table I) , w e 
told them that there was little probability (0.0000224, equivalent to 
1 in 44,6 19, according to Table I) of the iT having afFected children 
and that the risk of theil' children b eing carriers was 1/2 . T h e 
co uple has since had two healthy sons, bom in 1990 and 1996. T he 
second elder brother did not obtain genetic co unseling and has one 
healthy son . 
Case 2 In the siste r of XP220S and her husband, no mutatio;~ s 
were found in the three mutation sites (Fig 3) . From the result 
(genotype combination 1 in Table I) , we advised them that there 
was no chance of having an afFected child. An unafFec ted son was 
born that year. 
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Figure 2. AlwNI RFLP analysis shows that the brother of patient 
XPllOS is a carrier of the 13 mutation. PCP... product f.i·om the 
genomic DNA of XP11 OS, who is homozygous for the 13 mutation, shows 
two fragments of 84 bp and 244 bp after digestion with A lwNJ. PC R. 
product fro m the genomic DNA of her brother (ln11e A) shows three 
fragments of 84 bp , 244 bp, and 328 bp, meaning that he is a can-ier. PCR 
product f.i·om the genomic DNA of his spouse {lmte B) shows only one 
fragment of 328 bp , meaning that she is normal for the 13 sire of the XP-A 
gene. 
Case 3 In the brother of XP80S and his fiancee, no mutations 
were found in any of the tlrree mutation sites (Fig 4). The risk that 
the brother is a carrier of the unidentifi ed mutation is 1/2 (genotype 
combination 7 in Table I) . Thus, we advised them that there w as 
little probabil.ity (0.0000112, equivalent to 1 in 89,237, according 
to Table I) of having afFected children . T hey m arried , and tl1e wife 
deli vered an un afFected son in September 1996. 
DISCUSSION 
Preve ntion is undoubtedly th e preferred means of dealing with XP 
(Sato, ] 993; Valle, 1994) . Screening tests for newborns to identify 
individuals affected with XP are so expensive, time-consuming, and 
low in yie ld that tl1ey cannot be justified . Awareness of XP 
symptoms, however, will often permit diagnosis of a baby after his 
or her first sun exposure. Traditionally , most Japanese parents take 
th eir 1-mo-old babies to temples or shrines to pray for their h ealth 
and happin ess and then take the babies to visit their grandparents. 
Dm;ng the trips , the babies are often exposed to sunlight for severa.l 
hours. If the babies show severe reactions such as facial edem a and 
bliste rin g, the diagnosis can be sh·ongly suspected and the necessary 
diagnostic tests can be performe d . When early diagnosis is made , 
prevention of skin cancer through sun protection is possible (Sa to , 
1993) , ;md the parents of an affected individual are made aware of 
the risk to future offspring and are informed of the option of 
prenatal diagnosis . 
Approximately 450 XP patients are registered in Japan (Nish-
igori, 1993). Among them, 328 have been examined for their 
ultraviol et-induced unscheduled DNA synthesis (UDS) (Sato ~~ nl, 
1987). T h e number of patients who have less than 5% of normal 
UDS is 132. If th e patients are assum ed to belong to group A. who 
typically have the most severe DNA-repair deficiencies among all 
XP patients (Cleaver and Bootsma, 1975; Kraemer and Slor, 1985) , 
the tota l number of Japan ese XP-A patients is 132/ 328 X 450 = 
181. When we know the proportion of first-cousin marriages in a 
popula tion and the proportion of the afFected births that com e from 
marriages of first cousins, we can calculate th e frequency of a 
recessive gene accord ing to Dahlberg's equation (Sofaer, 1983). 
Because the frequency of first-cousin m arriages in an urban gen era.! 
population (Okazaki city, 1972-1983) (Imaizumi, 1986), c, is 0.26% 
and the frequency of first-cousin marriages among XP-A patients' 
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Table I. Probability of Having an Affected Child" 
Genotype" 
Com bination 
2 
3 
4 
5 
6 
7 
Proband 
3-13-' 
3-/3-
3-/3-
3-/?-" 
3-/?-
3- / ?-
3- 1?-
Genotype 
Sibling 
wt/wt" 
wt/3-
wt/3-
wt/3-
wt/3-
wt/wt or wt/?-
wt/ wt or wt/?-
"Spontaneous mutation in the XP-A gene is not considered. 
Spo use 
Any genotype 
wt/3-
wt/wt or wtf?J 
wt/3-
wt/wt or wt/?-
wt/3-
wt/wt or wt/?-
Probabili ty 
0 
1/4 = 0.25' 
:51/376 X 6/178 X 1/4 = 0.0000224-' 
1/4 = 0.25' 
S l/376 X 6/178 X 1 /4 = 0.0000224·' 
S l/2 X 1/4 = 0.125"··' 
:51/2 X 1/376 X 6/178 X 1/4 = 0.00001 12g 
11 Logicall y, there are seven possible combinati ons of XP-A gene stau1s fo r a pnticnt (proband}, sibl ing, and siblin g's spouse . 
,~ 3-, any combination of two of the three common mutations (e.xon 3, 13, and ex on 6). 
'
1 wt, w ild type. 
·· Prenata l dhtgnosis is offered if pa rents want to know the phenotype of a conceived cbil d befOre birth. 
f wt/wr o r we/?-. no m utation was found in the three cmnmon mutation sites by o ur PCR-RFLP ana lys is . 
. ~ Accordi.ng to 13ayes theorem, when unaffected children are horn consecutively, the conditional probability becom es lower. 1/376 is the freque ncy ofXP-A carriers in the 
Japanese pop ulatio n: 2pq X 10", where p ~ (l - q) and q ~ the frequency (0.00.133) of the mutated XP-A gene in the j apanese population: I o• = 1. 00.000.000 persons. 6/178 
is the tfcqucncy of unidentified XP-A mnt:ltions ofXP-A lllU tations cx:1m ined (6 alleles) I (89 affected persons) X (2 all eles I person). 
1
' ?-, unidcn tif~ed XP-A mutation. 
parents in Osaka, k, is 11% (Sa to K, unpublished data) , the 
freq ue ncy of m u tated XP- A genes in the Japanese population, q, is: 
q = c (1 - k)/16k- 15c- ck (Dahlberg's equation) = 0.00133. 
According to th e Hardy-Weinberg law (Levitan, 1988), the ex-
pected n umber of nonconsanguineous homozygotes for mutated 
XP-A genes is t/ X 108 = 177, assuming the J apanese population 
to be 100,000,000. T his number is very close to the estimated 
number of patients (181 individuals). XP- A heterozygotes are 
expected to be 2pq = 2 (1 - q) q = 0.00266 of the Japanese general 
population, equivalent to 1 in 376 persons. 
Calculations fi·om thi s paper and aJI published reports that show 
the m.u tation sites of the XP- A gene in XP-A patients (Nishigori, 
1993; Maeda et nl, 1994, 1995; Kondoh et al , 1995) reveal that 
among 89 patients (2 alleles/person X 89 persons = 178 a.ll eles), 
there are 5 mutations in exon 3 (1 homozygote), 150 mutations in 
the I3 site (65 homozygotes), 17 mutations in exon 6 (2 homozy-
gotes), and 6 unidentified mutations. These data permit quantita-
tive risk assessment for tlie offspring of persons w hose XP-A gene 
statu s is determi11 ed by PCR-RFLP analysis (Table 1). When a 
328bp ~ 
244bp~ 
84bp ~ 
B 
XP220S 
A XP220S 
Figure 3. A lrvNI RFLP analysis shows that both the sister of patient 
XP220S and her husband are normal for the XP-A I3 site . PCR 
product from the genomic DNA ofX1>220S, w ho was homozygous fo r the 
.13 mutation, shows two fragments of 84 bp and 244 bp "fter digestion with 
A lwNL PCR products from the genomic DNA of his sister (ln 11.e A) and her 
spouse (ln11.e B) show only one fragment of 328 bp, meaning that they are 
normal for the !3 site of the XP-A gene. 
proband is h om ozygous or compound heterozygous for any of the 
three mutations and his or her sibling has n o mutation in the three 
mutation sites, there is essentiall y a zero probability of having an 
affected child (ignoring the possibiJjty that the sibling's genom e 
contains a spontaneo us mutation in the XP- A gene not present in 
the parent, or the even less likely possibility that the mutated 
parental gen e inherited by the proband contain ed two mutations, 
on e of which was of the uncommon and undetectable type, which 
was transmitted to the proband's unaffected sibling as the result of 
a balanced translocation during gamete meiosis) . When siblings are 
heterozygous fo r one of the three mutations or are possibly 
heterozygous for an unide ntified mutation (a risk assigned as 1/2) 
and their spo uses are heterozygous for one of the three de tectable 
mutations (genotype combination s 2, 4, <md 6 in Table 1) , the 
probability of h aving an affected child is 1/4 or 1/8, respectively. In 
tlus case, counselors will explain th at prenatal diagnosis is available 
328bp~ 
244bp~ 
84bp ~ 
XPSOS 
A XPBOS B 
Figure 4. AlrvNI RFLP analysis shows that the brother of patient 
XP80S and his fiancee are normal for the XP-A 13 site. PCR product 
from the genomic DNA ofXP80S shows three fragments of84 bp, 244 bp, 
and 328 bp after digestion with A lwNJ , meaning that she was heterozygous 
for the J3 mutation and is considered to have an unidentified mutation in the 
other allele of the XP-A gene. The products fi·om genomic DNA of her 
brother (ln11e A) and his fiancee (ln11e B) show only one fragment of 328 bp, 
meaning that they are normal for the 13 site of the XP-A gene. 
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if the parents want assuran ce that th e ir unbo rn child is unaffected. 
Prenatal diagnosis ofXP-A gene status can be done by the analysis 
of UDS (Sato ef nl, 1987) or the post-ultraviol et colon y-forming 
ability of amn iotic cells (Sugita cl nl, 1982) or cho rio nic cell s 
(Suzumori et nl , 1994) , regardless of the suspected mutations. If the 
suspected mutation can be detected by PCR.-R.FLP, this m eth od 
can be substituted for UDS and offers the advantage of genetic 
counseling o f Japanese X P-A fi1miU es. 
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